Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Conifer Point Pharmaceuticals
Princeton, New Jersey, USAconiferpoint.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Conifer Point Pharmaceuticals specialized in computational chemistry and cheminformatics to accelerate early-stage drug discovery. Their proprietary tools enabled the design and prioritization of small molecules targeting challenging biological targets. The company was acquired by Lodo Therapeutics in August 2020 to enhance Lodo’s AI/ML-driven natural product drug discovery platform.
- Therapeutic areas
- OphthalmologyNeurologyInfectious Diseases
- Modalities
- Small moleculePeptidesNucleic acid therapeutics
- Industry
- Drug Discovery Services
Beyond the preview
Go deeper on Conifer Point Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Conifer Point Pharmaceuticals.